Want to see JP:5592 full AI Analyst Report?
Top Page
Kusurinomadoguchi, Inc.
(5592)
Select Model
Select Model
Rating:73Outperform
Price Target:
¥3,211.00
▲(20.67% Upside)
Action:Upgraded
Date:08/17/26
The score is driven primarily by strong financial growth but tempered by balance-sheet and cash-flow volatility (notably the sharp negative cash flow in 2025). Technicals are supportive due to a strong uptrend, though overbought signals add short-term risk. Valuation is a positive contributor given the low P/E and a modest dividend yield.
Positive Factors
Strong revenue and profit growth
Sustained expansion in revenue and net income indicates growing demand and improving operating scale. This provides a stronger earnings base over the next several quarters, although the latest margin mix remains less visible.
Negative Factors
Volatile leverage and asset base
Large changes in debt and total assets make the balance sheet harder to forecast and may reflect material financing or investment shifts. This reduces predictability and could complicate long-term capital allocation and risk assessment.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue and profit growth
Sustained expansion in revenue and net income indicates growing demand and improving operating scale. This provides a stronger earnings base over the next several quarters, although the latest margin mix remains less visible.
Read all positive factors
Kusurinomadoguchi, Inc. (5592) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥31.20B
Dividend Yield1.4%
Average Volume (3M)73.92K
Price to Earnings (P/E)9.6
Beta (1Y)0.64
Revenue Growth13.72%
EPS Growth43.20%
CountryJP
Employees491
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)263.13
Shares Outstanding11,459,482
10 Day Avg. Volume72,500
30 Day Avg. Volume73,916
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.41
Price to Sales (P/S)2.22
P/FCF Ratio9.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)188.9
Revenue Forecast (FY)¥14.30B
Kusurinomadoguchi, Inc. Business Overview & Revenue Model
Company Description
Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan, develops and implements a diverse array of technology solutions specifically designed for pharmacies and the wider medical care sector throughout the country. Its comp...
How the Company Makes Money
Publicly available, company-specific detail sufficient to describe Kusurinomadoguchi, Inc. (5592)'s revenue model (e.g., named revenue streams, pricing structure, and material partnerships) was not available in the provided context. null...
Kusurinomadoguchi, Inc. Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
66
Positive
Cash Flow
57
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.33B | 11.20B | 8.72B | 7.42B | 6.49B |
| Gross Profit | 6.97B | 6.48B | 4.93B | 4.07B | 3.37B |
| EBITDA | 4.19B | 2.97B | 2.35B | 1.68B | 1.51B |
| Net Income | 2.95B | 2.03B | 870.92M | 391.45M | 515.61M |
Balance Sheet | |||||
| Total Assets | 17.82B | 12.16B | 23.07B | 12.22B | 11.02B |
| Cash, Cash Equivalents and Short-Term Investments | 5.20B | 2.15B | 14.59B | 5.95B | 5.02B |
| Total Debt | 2.82B | 72.47M | 5.42B | 137.49M | 149.56M |
| Total Liabilities | 6.35B | 3.64B | 16.65B | 9.43B | 8.06B |
| Stockholders Equity | 11.35B | 8.45B | 6.37B | 2.70B | 2.45B |
Cash Flow | |||||
| Free Cash Flow | 2.93B | -5.37B | 999.21M | 1.57B | 2.58B |
| Operating Cash Flow | 2.95B | -5.33B | 2.63B | 3.10B | 3.66B |
| Investing Cash Flow | -2.30B | -1.80B | -1.79B | -1.54B | -541.10M |
| Financing Cash Flow | 2.22B | -5.36B | 7.81B | -635.39M | -564.83M |
Kusurinomadoguchi, Inc. Technical Analysis
Positive
2661.00
Price Trends
2464.74
Positive
2597.35
Positive
2626.30
Positive
Market Momentum
80.36
Negative
59.41
Neutral
40.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5592, the sentiment is Positive. The current price of 2661 is above the 20-day moving average (MA) of 2583.15, above the 50-day MA of 2464.74, and above the 200-day MA of 2626.30, indicating a bullish trend. The MACD of 80.36 indicates Negative momentum. The RSI at 59.41 is Neutral, neither overbought nor oversold. The STOCH value of 40.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5592.
Kusurinomadoguchi, Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥31.20B | 9.62 | ― | 1.03% | 13.72% | 43.20% | |
63 Neutral | ¥225.79B | 32.38 | ― | 0.43% | 18.89% | 11.66% | |
59 Neutral | ¥88.52B | 44.69 | 6.35% | ― | 24.03% | 34.50% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | ¥2.15B | -4.11 | ― | ― | 14.84% | 30.67% | |
44 Neutral | ¥9.60B | -20.70 | ― | ― | 7.39% | -27.75% |
* General Sector Average
JP:5592
Kusurinomadoguchi, Inc.
2,722.00
-1,039.01
-27.63%
JP:4480
Medley
2,687.00
203.00
8.17%
JP:4263
SUSMED,Inc.
470.00
-355.00
-43.03%
JP:4438
Welby Inc.
257.00
-81.00
-23.96%
JP:4483
JMDC Inc.
3,430.00
-727.77
-17.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.